IL13 and Hyperglycemia: While IL-13 inhibits gluconeogenesis in mouse experiments, a global IL13 knockout produces hyperglycemia, hepatic insulin resistance, and systemic metabolic dysfunction in mice of a C57BL/6 genetic background [59].